Login
Subscribe
Concerns over Efficacy and Cost of Muscle Wasting Treatments
Concerns over Efficacy and Cost of Muscle Wasting Treatments
Two new medications for treating a rare and deadly neuromuscular disease have high prices and questionable efficacies, say scientists.
Two new medications for treating a rare and deadly neuromuscular disease have high prices and questionable efficacies, say scientists.
pharma, drug development, FDA
Activities Discovered for Some Inactive Drug Ingredients
Ruth Williams | Jul 23, 2020 | 4 min read
Screens of hundreds of drug excipients reveal that some can interact with biological targets, contradicting their FDA categorization as inert.
Former FDA Commissioner Frank Young Dies
Jef Akst | Dec 2, 2019 | 2 min read
The physician-researcher laid the groundwork for genetic cloning and led the US Food and Drug Administration as the country faced the AIDS crisis in the 1980s.
TS Picks: September 8, 2015
Jef Akst | Sep 8, 2015 | 1 min read
Pharma edition
Lazarus Drugs
Kate Yandell | Feb 1, 2015 | 8 min read
While some drugs sail through development, others suffer setbacks, including FDA rejections, before reaching the market.
Obama Signs FDA Bill
Bob Grant | Jul 11, 2012 | 2 min read
The new law reauthorizes fees charged to drug and device makers, creates new fees for the approval of generic drugs.